You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API cyclobenzaprine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing cyclobenzaprine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Direct_Rx CYCLOBENZAPRINE HCL ER cyclobenzaprine hcl er 72189-362 DIETHYL PHTHALATE
Direct_Rx CYCLOBENZAPRINE HCL ER cyclobenzaprine hcl er 72189-362 ETHYLCELLULOSE
Direct_Rx CYCLOBENZAPRINE HCL ER cyclobenzaprine hcl er 72189-362 FD&C BLUE NO. 1
Direct_Rx CYCLOBENZAPRINE HCL ER cyclobenzaprine hcl er 72189-362 FD&C BLUE NO. 2
Direct_Rx CYCLOBENZAPRINE HCL ER cyclobenzaprine hcl er 72189-362 FD&C RED NO. 40
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing cyclobenzaprine

Company Ingredient NDC Excipient
NCS HealthCare of KY LLC dba Vangard Labs cyclobenzaprine 0615-8084 CELLULOSE, MICROCRYSTALLINE
NCS HealthCare of KY LLC dba Vangard Labs cyclobenzaprine 0615-8084 FERRIC OXIDE YELLOW
NCS HealthCare of KY LLC dba Vangard Labs cyclobenzaprine 0615-8084 HYPROMELLOSES
NCS HealthCare of KY LLC dba Vangard Labs cyclobenzaprine 0615-8084 LACTOSE MONOHYDRATE
NCS HealthCare of KY LLC dba Vangard Labs cyclobenzaprine 0615-8084 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for cyclobenzaprine

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

cyclobenzaprine drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Company Ingredient NDC
Teva Pharmaceuticals USA Inc cyclobenzaprine hydrochloride 0093-3420
Liberty Pharmaceuticals Inc cyclobenzaprine hydrochloride 0440-1350
Liberty Pharmaceuticals Inc cyclobenzaprine hydrochloride 0440-7350
Actavis Pharma Inc cyclobenzaprine hydrochloride 0591-3256
Blenheim Pharmacal Inc cyclobenzaprine hydrochloride 10544-072
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: DIETHYL PHTHALATE

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C GREEN NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224

Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 16070722

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYL ALCOHOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

cyclobenzaprine drug variants containing MICROCRYSTALLINE CELLULOSE 102

Company Ingredient NDC
NCS HealthCare of KY LLC dba Vangard Labs cyclobenzaprine hydrochloride 0615-8508
Unichem Pharmaceuticals (USA) Inc cyclobenzaprine hydrochloride 29300-413
A-S Medication Solutions cyclobenzaprine hydrochloride 50090-5711
A-S Medication Solutions cyclobenzaprine hydrochloride 50090-5712
A-S Medication Solutions cyclobenzaprine hydrochloride 50090-5713
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1000

Excipient focus: POLYETHYLENE GLYCOL 1450

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

cyclobenzaprine drug variants containing POLYETHYLENE GLYCOLS

Company Ingredient NDC
Liberty Pharmaceuticals Inc cyclobenzaprine hydrochloride 0440-1350
Liberty Pharmaceuticals Inc cyclobenzaprine hydrochloride 0440-7350
NCS HealthCare of KY Inc dba Vangard Labs cyclobenzaprine hydrochloride 0615-7528
Blenheim Pharmacal Inc cyclobenzaprine hydrochloride 10544-072
Blenheim Pharmacal Inc cyclobenzaprine hydrochloride 10544-200
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

cyclobenzaprine drug variants containing TRIACETIN

Company Ingredient NDC
Mylan Pharmaceuticals Inc cyclobenzaprine hydrochloride 0378-0771
NCS HealthCare of KY LLC dba Vangard Labs cyclobenzaprine hydrochloride 0615-8508
Unichem Pharmaceuticals (USA) Inc cyclobenzaprine hydrochloride 29300-413
A-S Medication Solutions cyclobenzaprine hydrochloride 50090-5711
A-S Medication Solutions cyclobenzaprine hydrochloride 50090-5712
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group